Assertio Stock Discussion

$Assertio (ASRT.US)$
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
Friday, 13th December at 8:00 am
LAKE FOREST, Ill., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced yesterday results of a clinical trial investigating the utility of Rolvedon® (eflapegrastim-x...

$Assertio (ASRT.US)$ anybody watching this?

$Assertio (ASRT.US)$
Underated/Valued, overlooked, great buy!!!

$Assertio (ASRT.US)$
This one is killin it....

$Assertio (ASRT.US)$ 👀bouncing up from 5 year low